A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

著者: Melssen, Marit M., Petroni, Gina R., Chianese-Bullock, Kimberly A., Wages, Nolan A., Grosh, William W., Varhegyi, Nikole, Smolkin, Mark E., Smith, Kelly T., Galeassi, Nadejda V., Deacon, Donna H., Gaughan, Elizabeth M., Slingluff, Craig L.
出版年 J Immunother Cancer (2019)

A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites

著者: Slingluff, Craig L., Petroni, Gina R., Olson, Walter C., Smolkin, Mark E., Chianese-Bullock, Kimberly A., Mauldin, Ileana S., Smith, Kelly T., Deacon, Donna H., Varhegyi, Nikole E., Donnelly, Sean B., Reed, Caroline M., Scott, Kristy, Galeassi, Nadejda V., Grosh, William W.
出版年 Cancer Immunol Immunother (2015)

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

著者: Slingluff, Jr., Craig L, Petroni, Gina R, Chianese-Bullock, Kimberly A, Wages, Nolan A, Olson, Walter C, Smith, Kelly T, Haden, Kathleen, Dengel, Lynn T, Dickinson, Anna, Reed, Caroline, Gaughan, Elizabeth M, Grosh, William W, Kaur, Varinder, Varhegyi, Nikole, Smolkin, Mark, Galeassi, Nadejda V, Deacon, Donna, Hall, Emily H
出版年 J Immunother Cancer (2021)